 |
|
|
|
|
 |
Last Updated: Jan 5, 2010 - 1:51:01 PM |
Latest Research
:
Infectious Diseases
:
HCV
Caffeine intake in chronic hepatitis C patients associated with less liver fibrosis
Researchers from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) determined that patients with chronic hepatitis C virus (HCV) who consumed more than 308 mg of caffeine daily had milder liver fibrosis.
Jan 5, 2010 - 1:41:15 PM
|
Latest Research
:
Infectious Diseases
:
HCV
Bavituximab Shows Promising Anti-Viral Activity in Monotherapy HCV Trial
Peregrine Pharmaceuticals, a biopharmaceutical company developing targeted therapeutics for the treatment of cancer and hepatitis C virus infections, today reported top-line results on the effect of bavituximab (formerly Tarvacin) on viral RNA serum titers when administered as single dose monotherapy in a Phase Ia study in patients with chronic hepatitis C virus (HCV) infection. In this analysis, bavituximab showed signs of anti-viral activity at all four study dose levels, and it also showed evidence of a prolonged anti-viral effect.
Jun 8, 2006 - 6:17:37 AM
|
Latest Research
:
Infectious Diseases
:
HCV
Treating obesity improves efficacy of hepatitis C therapy
According to a new study, obese patients chronically infected with the hepatitis C virus (HCV) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue are corrected. Weight loss, medications to decrease insulin resistance and extending duration or dosage of therapy are strategies that may improve the efficacy of therapy.
Jun 3, 2006 - 9:43:37 AM
|
Latest Research
:
Infectious Diseases
:
HCV
Molecular mechanism that inhibits HCV replication discovered - Tang-Nelson study
The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for experimental research.
Feb 8, 2006 - 11:37:37 AM
|
Latest Research
:
Infectious Diseases
:
HCV
Extrahepatic sites may cause rapid recurrence of Hepatitis C after liver transplantation
When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-transplant levels within a few days, according to a new study published in the February 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).
Feb 3, 2006 - 4:02:37 PM
|
Latest Research
:
Infectious Diseases
:
HCV
How Hepatitis C virus highjack protein synthesis machinery in humans
Scientists have uncovered key new information towards understanding the crucial first step in protein synthesis, the process by which the genetic code, harbored within DNA and copied into RNA, is translated into the production of proteins. This new information also helps to explain how viruses, such as Hepatitis C, are able to highjack protein synthesis machinery in humans for their own purposes.
Dec 4, 2005 - 10:10:38 AM
|
Latest Research
:
Infectious Diseases
:
HCV
Breastfeeding does not raise risk of HCV transmission
Breastfeeding does not raise the risk of mother-to-child transmission of hepatitis C virus (HCV), according to two new studies published in the December 1 issue of The Journal of Infectious Diseases, now available online.
Nov 1, 2005 - 12:52:38 PM
|
Latest Research
:
Infectious Diseases
:
HCV
Celgosivir Cleared for Phase IIb Combination Study in HCV Non-responders
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, has received a Notice of Authorization from Health Canada for a clinical trial application (CTA) to begin a Phase IIb combination study of MX-3253 (celgosivir), a compound in development for the treatment of chronic hepatitis C virus (HCV) infections. Enrollment in the study is expected to commence in the next few weeks with results expected around mid- year calendar 2006.
Aug 11, 2005 - 11:18:38 PM
|
Latest Research
:
Infectious Diseases
:
HCV
Albuferon in Phase 2b Trial for the Treatment of Chronic Hepatitis C
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2b clinical trial of Albuferon(TM) (albumin-interferon alpha) in combination with ribavirin to evaluate the efficacy and safety of Albuferon in patients with chronic hepatitis C virus (HCV) genotype 1 who are naive to interferon alpha-based treatment regimens. Genotype 1 accounts for nearly 70% of all HCV infections in North America and is generally regarded as the most difficult HCV genotype to treat.(1)
Jun 2, 2005 - 1:15:38 PM
|
Latest Research
:
Infectious Diseases
:
HCV
Valopicitabine Shows Potential Therapeutic Response in the Treatment of Genotype 1 Hepatitis C Patients
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX - News), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced preliminary phase IIa clinical trial data for valopicitabine (NM283) in treatment naive genotype 1 hepatitis C patients.
Apr 14, 2005 - 8:32:38 PM
|
<< prev
next >>
|
|
|
|
| Health |
Musculoskeletal problems ail computer workers
|
Eating less may help you live longer
|
IOM report on national vaccine plan
|
You may damage knees if you're an exercise freak
|
American adults receiving flu vaccine at about the same rate as in 2008, study finds
|
Widowed people have higher mortality
|
Anxious women more likely to have smaller babies
|
UIC receives $1 million grant to study 'fat taxes,' diet, obesity
|
Progress made on group B streptococcus vaccine
|
Exercise addiction could prove fatal
|
| | Healthcare |
Biotech industry hails tax sops in Indian budget
|
Junior doctors in Madhya Pradesh call off strike
|
25000 NRI Doctors Could Return to India from UK
|
AIIMS to guide 40 medical colleges on drug reaction
|
15 percent of Indian women below 50 are obese: Azad
|
Mexico expects swine flu infections to peak at New Year
|
Wipro unveils new application for remote healthcare
|
Azad hikes funds for cancer control, treatment of poor
|
Kerala medical colleges doctors suspend agitation
|
Delhi records 280 cases of dengue
|
| | Latest Research |
Belatacept may preserve renal function better than calcineurin inhibitors in kidney transplantation
|
K-State professor finds link between low oxygen levels in body and cancer-aiding protein
|
HHMI's Gilliam Fellowships aim to increase diversity in the sciences
|
Saving lives one breath at a time
|
Improvements needed in genomic test result discussions
|
Occupational sunlight exposure and kidney cancer risk in men
|
The life and death of online communities
|
Deep sedimentation of acantharian cysts -- a reproductive strategy?
|
Adele Boskey 2010 recipient of ORS/AOA award for lifetime contributions to orthopedics
|
National Jewish Health receives grant to learn how families cope with food allergy
|
| | Medical News |
Azad invites NRI investment in pharmaceuticals, medical education
|
25000 NRI Doctors Could Return to India from UK
|
Eat pistachio to lower blood sugar
|
Stricter resident doctor duty hour required to prevent medical errors
|
Chandigarh adult drinks 11 bottles a month
|
Swine flu vaccine nearing development: Official
|
India to be diabetes' world capital by 2025: Expert
|
US may allow 5,000 more Indian doctors for residency training
|
Scissors taken out from man's stomach after two years
|
India's swine flu toll reaches 967, over 26,000 infected
|
| | Special Topics |
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
Spiders which eat together, stay together and multiply
|
Anna Hazare - the keeper of the earth and human conscience
|
Indian American scientist wins top IMO prize
|
Artificial human sperm could make men redundant: experts
|
Will autopsy on Benazir's body become necessary?
|
|
|
